Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki
Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Gennady Schweigert and Pavel Mileiko acquire 50% stake in Nanolek LLC
Nanolek LLC informs about changes in the ownership structure:...
The EEC Council approved the Requirements to patient information leaflet
At its meeting held on January 21, the Eurasian Economic Commission's Council approved an amended version of the Requirements to Patient Information Leaflet and Summary of Product Characteristics.
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU
On February 25, a working meeting of experts was...
Recommendations on registering medical devices in EAEU adopted
On December 23, the Eurasian Economic Commission's Board meeting...
The EEC Collegium approved amendments to the rules for determining OTC categories of medicines
According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia
Rules of import and export of biomaterials produced during...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research
Cerebras Systems, the pioneer in high performance artificial intelligence...
Hello Heart raises $70 million to support growth in customer demand
Hello Heart, the only digital therapeutic that focuses on...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki
Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Gennady Schweigert and Pavel Mileiko acquire 50% stake in Nanolek LLC
Nanolek LLC informs about changes in the ownership structure:...
The EEC Council approved the Requirements to patient information leaflet
At its meeting held on January 21, the Eurasian Economic Commission's Council approved an amended version of the Requirements to Patient Information Leaflet and Summary of Product Characteristics.
Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister...
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU
On February 25, a working meeting of experts was...
Recommendations on registering medical devices in EAEU adopted
On December 23, the Eurasian Economic Commission's Board meeting...
The EEC Collegium approved amendments to the rules for determining OTC categories of medicines
According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia
Rules of import and export of biomaterials produced during...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research
Cerebras Systems, the pioneer in high performance artificial intelligence...
Hello Heart raises $70 million to support growth in customer demand
Hello Heart, the only digital therapeutic that focuses on...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
FEFU to Launch Russia’s First University-Based GMP Site for Biologics
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.
Content Marketing in Pharma: How to Turn Production Capabilities into Reputational
The days of "silence" in B2B pharma are over. A decade ago, manufacturing plants could operate quietly for years, relying solely on the personal networks of their commercial directors. Today, such a strategy is a brake on growth.
Newsletter
Get important news delivered directly to your inbox and stay connected!
© PHARMPROM 2026